Garth L. Nicolson
9Patents
5h-index
8Co-inventors
56Inventor score
Filing activity: Apr 1, 1986 → May 8, 2020
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US5262403A | Glycosaminoglycan derivatives and their use as inhibitors of tumor invasiveness of metastatic profusion-II | Physics | 31 | Expired |
| US4859581A | Endoglycosidase assay | Physics | 25 | Expired |
| US5332812A | Solid-phase substrate containing modified heparin | Physics | 21 | Expired |
| US5030559A | Methods and compositions for the identification of metastatic human tumors | Emerging Cross-Sectional Technologies | 11 | Expired |
| US5393534A | Liver-derived tumor cell growth inhibitor | Emerging Cross-Sectional Technologies | 7 | Expired |
| US5164489A | Lung growth stimulatory and inhibitory factors for carcinoma tumor cells | Human Necessities | 0 | Expired |
| US11253531B2 | Lipid supplements for reducing nerve action potentials | Human Necessities | 0 | Active |
| US10421943B2 | Phospholipid compositions and use thereof to enhance spermatozoa motility, viability and resistance to oxydative damage | Chemistry; Metallurgy | 0 | Active |
| US9861656B2 | Phospholipid compositions and use thereof to enhance spermatozoa motility and viability | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.